CLINICAL_TRIALS
trial_result
· 2026-02-09
Clinical Trial Update: Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer [Phase 1]
Summary
Phase 1 study evaluating the combination of focused ultrasound with pembrolizumab in metastatic breast cancer has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Patrick Dillon, MD | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED | Results posted: 2026-02-09